Markus Wallwiener
0000-0002-4139-9340
Publication & Citation Trends
Publications
0 total
Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial
Cited by 0
Semantic Scholar
Correction: ENABLE—App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled Trial
Cited by 0
Semantic Scholar
Successful bilateral ureteral occlusion using liquid embolization for anastomotic insufficiency and insufficiency of an ileal conduit
Cited by 0
Semantic Scholar
Preuse Acceptance of a Family-Centered, Need-Based, and Interprofessional Perinatal Care Mobile Health Intervention: Exploratory Study
Cited by 0
Semantic Scholar
ENABLE—App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled Trial OA
Cited by 3
Semantic Scholar
App-based assessment of patient-reported outcomes in the Molecular Tumor Board in the Center for Personalized Medicine-(TRACE).
Cited by 1
Semantic Scholar
The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial
Cited by 1
Semantic Scholar
Usability and User Experience of an mHealth App for Therapy Support of Patients With Breast Cancer: Mixed Methods Study Using Eye Tracking OA
Cited by 14
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(147)
Cancer Cells and Metastasis
(82)
Advanced Breast Cancer Therapies
(68)
Cancer Genomics and Diagnostics
(67)
Uterine Myomas and Treatments
(57)
Affiliations
Goethe University Frankfurt
Oslo University Hospital
German Society of Surgery
Universität Hamburg
German Cancer Research Center